Renalytix Plc
RNLX · NASDAQ
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $25 | $41 | $65 |
| Short-Term Investments | $0 | $1 | $3 | $9 |
| Receivables | $0 | $1 | $1 | $0 |
| Inventory | $0 | $0 | $1 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $6 | $28 | $47 | $76 |
| Property Plant & Equip (Net) | $0 | $1 | $3 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $13 | $14 | $18 |
| Long-Term Investments | $0 | $1 | -$3 | $0 |
| Tax Assets | $0 | -$1 | $0 | $7 |
| Other NC Assets | $2 | $0 | $1 | -$1 |
| Total NC Assets | $2 | $14 | $16 | $27 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $8 | $42 | $63 | $103 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $2 |
| Short-Term Debt | $4 | $5 | $5 | $0 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | -$0 | $0 | $0 |
| Other Curr. Liab. | $5 | $9 | $5 | $4 |
| Total Curr. Liab. | $11 | $16 | $12 | $7 |
| LT Debt | $4 | $8 | $8 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $8 | $8 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $16 | $24 | $20 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $1 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$212 | -$99 | -$53 | $4 |
| AOCI | $0 | -$1 | -$1 | $8 |
| Other Equity | $203 | $186 | $164 | $150 |
| Total Equity | -$8 | $18 | $43 | $95 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $8 | $42 | $63 | $103 |
| Net Debt | $4 | -$13 | -$29 | -$65 |